loading
前日終値:
$3.16
開ける:
$3.14
24時間の取引高:
5.16M
Relative Volume:
1.63
時価総額:
$892.04M
収益:
$8.10M
当期純損益:
$-92.72M
株価収益率:
-9.6176
EPS:
-0.34
ネットキャッシュフロー:
$-82.52M
1週間 パフォーマンス:
+11.99%
1か月 パフォーマンス:
+11.99%
6か月 パフォーマンス:
+135.25%
1年 パフォーマンス:
+62.69%
1日の値動き範囲:
Value
$3.11
$3.30
1週間の範囲:
Value
$2.91
$3.30
52週間の値動き範囲:
Value
$1.05
$3.40

Taysha Gene Therapies Inc Stock (TSHA) Company Profile

Name
名前
Taysha Gene Therapies Inc
Name
セクター
Healthcare (1147)
Name
電話
(214) 612-0000
Name
住所
3000 PEGASUS PARK DRIVE, DALLAS
Name
職員
73
Name
Twitter
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
TSHA's Discussions on Twitter

TSHA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
TSHA
Taysha Gene Therapies Inc
3.27 862.03M 8.10M -92.72M -82.52M -0.34
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
391.64 101.35B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.00 58.66B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
562.27 59.43B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
737.56 44.01B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
340.70 36.56B 3.81B -644.79M -669.77M -6.24

Taysha Gene Therapies Inc Stock (TSHA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-11 開始されました BofA Securities Buy
2024-06-27 開始されました BMO Capital Markets Outperform
2024-04-09 開始されました Piper Sandler Overweight
2023-02-01 ダウングレード Jefferies Buy → Hold
2023-01-27 ダウングレード Morgan Stanley Overweight → Equal-Weight
2022-11-09 ダウングレード Goldman Buy → Neutral
2022-03-09 開始されました Robert W. Baird Outperform
2022-03-01 開始されました Wells Fargo Overweight
2022-02-18 開始されました SMBC Nikko Outperform
2021-12-16 開始されました Guggenheim Buy
2021-07-16 開始されました Needham Buy
2021-06-24 開始されました Truist Buy
2021-06-15 開始されました BTIG Research Buy
2021-06-09 開始されました Wedbush Outperform
2021-06-08 開始されました JMP Securities Mkt Outperform
2021-05-19 開始されました Cantor Fitzgerald Overweight
2021-05-11 再開されました Jefferies Buy
2021-02-24 開始されました William Blair Outperform
2021-01-05 開始されました Oppenheimer Outperform
2020-10-19 開始されました Chardan Capital Markets Buy
2020-10-19 開始されました Goldman Buy
2020-10-19 開始されました Jefferies Buy
2020-10-19 開始されました Morgan Stanley Overweight
すべてを表示

Taysha Gene Therapies Inc (TSHA) 最新ニュース

pulisher
Sep 30, 2025

Analyzing drawdowns of Taysha Gene Therapies Inc. with statistical toolsEarnings Growth Summary & Stepwise Swing Trade Plans - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

Taysha Gene Therapies (NASDAQ:TSHA) Trading Down 4.5%Time to Sell? - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

Will Taysha Gene Therapies Inc. stock continue dividend increases2025 Price Momentum & Consistent Income Trade Ideas - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Will Taysha Gene Therapies Inc. stock maintain growth story2025 Institutional Moves & Community Consensus Picks - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Is Taysha Gene Therapies Inc. trending in predictive chart modelsWeekly Trade Summary & Weekly Stock Performance Updates - newser.com

Sep 29, 2025
pulisher
Sep 28, 2025

What analysts say about Taysha Gene Therapies Inc stockDouble Top/Bottom Patterns & Turn Data into Profits With Our Strategies - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

Should You Track Rapid Investments Limited as a LongTerm Growth PlayWeekly Market Snapshot & Grow Smarter With Pro-Level Research - Early Times

Sep 28, 2025
pulisher
Sep 28, 2025

What drives Taysha Gene Therapies Inc stock priceCapital Gains Strategies & Rapid Profit Portfolio - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Sep 27, 2025
pulisher
Sep 26, 2025

Taysha Gene Therapies, Inc. $TSHA Shares Sold by Goldman Sachs Group Inc. - MarketBeat

Sep 26, 2025
pulisher
Sep 24, 2025

Taysha Gene Therapies, Inc. Experiences Revision in Stock Evaluation Amid Strong Performance - Markets Mojo

Sep 24, 2025
pulisher
Sep 24, 2025

Taysha Gene Therapies (NASDAQ:TSHA) Shares Up 8%Time to Buy? - MarketBeat

Sep 24, 2025
pulisher
Sep 22, 2025

Cantor Fitzgerald reiterates Overweight rating on Taysha Gene Therapies stock - Investing.com

Sep 22, 2025
pulisher
Sep 19, 2025

Taysha Gene Therapies (NASDAQ:TSHA) Stock Price Down 4.4% on Insider Selling - MarketBeat

Sep 19, 2025
pulisher
Sep 19, 2025

Combining price and volume data for Taysha Gene Therapies Inc.M&A Rumor & Long-Term Safe Investment Ideas - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Sentiment analysis tools applied to Taysha Gene Therapies Inc.Earnings Growth Summary & Expert Curated Trade Setup Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Bank Watch: Can TNONW maintain its current growth rateWeekly Trade Recap & Technical Pattern Based Signals - khodrobank.com

Sep 19, 2025
pulisher
Sep 18, 2025

Is this a good reentry point in Taysha Gene Therapies Inc.2025 Market Trends & Long Hold Capital Preservation Plans - newser.com

Sep 18, 2025
pulisher
Sep 18, 2025

Breakout Watch: What is the next catalyst for Taysha Gene Therapies IncJuly 2025 Movers & Daily Volume Surge Trade Alerts - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Is Taysha Gene Therapies Inc. building a consolidation baseShort Setup & Capital Efficient Trade Techniques - newser.com

Sep 18, 2025
pulisher
Sep 18, 2025

Live market analysis of Taysha Gene Therapies Inc.2025 Top Gainers & Smart Allocation Stock Tips - newser.com

Sep 18, 2025
pulisher
Sep 17, 2025

Taysha Gene Therapies, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Sep 17, 2025
pulisher
Sep 17, 2025

Insider Selling: Taysha Gene Therapies (NASDAQ:TSHA) Insider Sells 200,000 Shares of Stock - MarketBeat

Sep 17, 2025
pulisher
Sep 16, 2025

Siren L.L.C. Has $9.06 Million Stock Holdings in Taysha Gene Therapies, Inc. $TSHA - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

Downgrade Watch: How liquid is Taysha Gene Therapies Inc stockQuarterly Market Summary & Reliable Price Breakout Alerts - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Published on: 2025-09-16 23:25:17 - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Tech Rally: Will Taysha Gene Therapies Inc benefit from AI trendsProfit Target & Consistent Growth Equity Picks - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Returns Recap: How correlated is Taysha Gene Therapies Inc to the S P5002025 Top Gainers & Precise Entry and Exit Recommendations - خودرو بانک

Sep 16, 2025
pulisher
Sep 15, 2025

Risk Hedge: Is QUAD stock a falling knife or bargain buyJuly 2025 Sector Moves & Real-Time Market Trend Scan - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Insider Buy: Is Taysha Gene Therapies Inc attractive for institutional investors2025 Technical Patterns & Free Expert Verified Stock Movement Alerts - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Quarterly Recap: Is Taysha Gene Therapies Inc. subject to activist investor interestOptions Play & Community Consensus Trade Signals - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Aug Mood: What is the next catalyst for Taysha Gene Therapies IncJuly 2025 Update & Daily Growth Stock Tips - khodrobank.com

Sep 15, 2025
pulisher
Sep 15, 2025

Quarterly Recap: How liquid is Taysha Gene Therapies Inc. stockQuarterly Market Summary & AI Driven Stock Reports - خودرو بانک

Sep 15, 2025
pulisher
Sep 14, 2025

How to read the order book for Taysha Gene Therapies Inc.Market Risk Report & Verified Technical Trade Signals - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Taysha Gene Therapies, Inc. $TSHA Shares Purchased by Octagon Capital Advisors LP - MarketBeat

Sep 14, 2025
pulisher
Sep 08, 2025

Screener Results Flag Taysha Gene Therapies Inc. as OversoldTrade Risk Summary & Verified Entry Point Signals - beatles.ru

Sep 08, 2025
pulisher
Sep 08, 2025

Nuveen LLC Acquires New Holdings in Taysha Gene Therapies, Inc. $TSHA - MarketBeat

Sep 08, 2025
pulisher
Sep 07, 2025

ADAR1 Capital Management LLC Purchases 888,602 Shares of Taysha Gene Therapies, Inc. $TSHA - MarketBeat

Sep 07, 2025
pulisher
Sep 06, 2025

Published on: 2025-09-06 13:01:15 - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Real time breakdown of Taysha Gene Therapies Inc. stock performance2025 Analyst Calls & Momentum Based Trading Signals - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Volume Report: Is Taysha Gene Therapies Inc. benefiting from interest rate changesJuly 2025 Highlights & Low Risk High Reward Ideas - خودرو بانک

Sep 06, 2025
pulisher
Sep 05, 2025

Taysha Gene Therapies Inc. stock prediction for this weekJobs Report & Verified Short-Term Plans - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Aug Highlights: Can Taysha Gene Therapies Inc. outperform under higher oil pricesEarnings Growth Report & Fast Moving Stock Watchlists - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Published on: 2025-09-05 16:05:08 - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

What institutional flow reveals about Taysha Gene Therapies Inc.2025 Winners & Losers & Daily Profit Focused Screening - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Is Taysha Gene Therapies Inc. stock entering bullish territoryQuarterly Market Review & Comprehensive Market Scan Reports - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Trapped Investors in Taysha Gene Therapies Inc. Await Breakout SignalJuly 2025 Momentum & Consistent Growth Equity Picks - beatles.ru

Sep 05, 2025
pulisher
Sep 05, 2025

Taysha Gene Therapies announces inducement grant under Nasdaq listing rule 5635(c)(4) - MarketScreener

Sep 05, 2025
pulisher
Sep 05, 2025

Taysha Gene Therapies announces inducement grant under Nasdaq listing rule - TipRanks

Sep 05, 2025
pulisher
Sep 05, 2025

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Li - GuruFocus

Sep 05, 2025
pulisher
Sep 05, 2025

Taysha Gene Therapies (TSHA) Awards Stock Options to New Employe - GuruFocus

Sep 05, 2025

Taysha Gene Therapies Inc (TSHA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.66
price down icon 2.36%
$84.81
price up icon 1.10%
$30.67
price up icon 4.57%
$98.62
price up icon 0.53%
$144.01
price up icon 1.67%
biotechnology ONC
$340.70
price up icon 2.36%
大文字化:     |  ボリューム (24 時間):